JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 5, 2004; DOI: 10.1124/jpet.103.061150


0022-3565/04/3092-684-691$20.00
JPET 309:684-691, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.061150v1
309/2/684    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okajima, K.
Right arrow Articles by Isobe, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okajima, K.
Right arrow Articles by Isobe, H.

CARDIOVASCULAR

Activation of Capsaicin-Sensitive Sensory Neurons by Carvedilol, a Nonselective {beta}-Blocker, in Spontaneous Hypertensive Rats

Kenji Okajima, Naoaki Harada, Mitsuhiro Uchiba, and Hirotaka Isobe

Department of Diagnostic Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

We performed a study in spontaneous hypertensive rats (SHR) to determine whether carvedilol, a nonselective {beta}-adrenoceptor antagonist, activates capsaicin-sensitive sensory neurons (CSSNs), thereby promoting the release of calcitonin gene-related peptide (CGRP), a neuropeptide with an important role in maintenance of cardiovascular homeostasis. Carvedilol given intravenously at a dose of 0.3 mg/kg transiently decreased the mean arterial blood pressure (MABP) and increased renal tissue blood flow with increases in CGRP levels in plasma and kidney. These effects induced by carvedilol were not seen in animals pretreated with capsazepine, an antagonist of capsaicin. Although 1.0 mg/kg cavedilol markedly decreased MABP, it neither increased renal tissue blood flow nor CGRP levels in plasma and kidney. Prazosin, a selective {alpha}1-adrenoceptor antagonist, and bisoprolol, a selective {beta}1-adrenoceptor antagonist, decreased MABP with capsazepine, showing no antagonistic action in either cases, and these agents increased neither renal tissue blood flow nor levels of CGRP in plasma and kidney. Both ICI 118,551 [(±)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol], a selective {beta}2-adrenoceptor antagonist, at a dose of 0.25 mg/kg and capsaicin mimicked effects induced by 0.3 mg/kg carvedilol. Administration of 1.0 mg/kg ICI 118,551 produced effects similar to those induced by 1.0 mg/kg carvedilol. These observations strongly suggested that the low dose of carvedilol might activate CSSNs in SHR to increase the release of CGRP, thereby decreasing blood pressure with an increase in renal tissue blood flow. The effects induced by carvedilol seemed to be mediated by its {beta}2-adrenoceptor blockade activity.


Received October 7, 2003; accepted February 5, 2004.

Address correspondence to: Dr. Kenji Okajima, Department of Diagnostic Medicine, Graduate School of Medical Sciences, Kumamoto University, Honjo, 1-1-1 Kumamoto 860-0811, Japan. E-mail: whynot{at}kaiju.medic.kumamoto-u.ac.jp




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Bhatia, L. Zhi, H. Zhang, S.-W. Ng, and P. K. Moore
Role of substance P in hydrogen sulfide-induced pulmonary inflammation in mice
Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L896 - L904.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.